These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28787020)

  • 1. Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia.
    Cillóniz C; Ceccato A; de la Calle C; Gabarrús A; Garcia-Vidal C; Almela M; Soriano A; Martinez JA; Marco F; Vila J; Torres A
    PLoS One; 2017; 12(8):e0182436. PubMed ID: 28787020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response.
    Bordon JM; Fernandez-Botran R; Wiemken TL; Peyrani P; Uriarte SM; Arnold FW; Rodriquez-Hernandez L; Rane MJ; Kelley RR; Binford LE; Uppatla S; Cavallazzi R; Blasi F; Aliberti S; Restrepo MI; Fazeli S; Mathur A; Rahmani M; Ayesu K; Ramirez J
    Infection; 2015 Dec; 43(6):729-38. PubMed ID: 26424683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive Disease vs Urinary Antigen-Confirmed Pneumococcal Community-Acquired Pneumonia.
    Ceccato A; Torres A; Cilloniz C; Amaro R; Gabarrus A; Polverino E; Prina E; Garcia-Vidal C; Muñoz-Conejero E; Mendez C; Cifuentes I; Puig de la Bella Casa J; Menendez R; Niederman MS
    Chest; 2017 Jun; 151(6):1311-1319. PubMed ID: 28093269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study.
    Bordón J; Peyrani P; Brock GN; Blasi F; Rello J; File T; Ramirez J;
    Chest; 2008 Mar; 133(3):618-24. PubMed ID: 18198264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia.
    Amaro R; Liapikou A; Cilloniz C; Gabarrus A; Marco F; Sellares J; Polverino E; Garau J; Ferrer M; Musher DM; Torres A
    Eur Respir J; 2016 Sep; 48(3):797-807. PubMed ID: 27174880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors and mortality in immunocompetent adult patients hospitalized with community-acquired pneumococcal pneumonia].
    Saldías P F; Viviani G P; Pulgar B D; Valenzuela F F; Paredes E S; Díaz P O
    Rev Med Chil; 2009 Dec; 137(12):1545-52. PubMed ID: 20361129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical predictors of bacteremia in immunocompetent adult patients hospitalized for community-acquired pneumonia].
    Saldías P F; Reyes B T; Sáez B J; Rain M C; Illanes C P; Briceño V C; Díaz P O
    Rev Med Chil; 2015 May; 143(5):553-61. PubMed ID: 26203565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumoniae.
    Lin SH; Lai CC; Tan CK; Liao WH; Hsueh PR
    Epidemiol Infect; 2011 Sep; 139(9):1307-16. PubMed ID: 20974020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study.
    Mongardon N; Max A; Bouglé A; Pène F; Lemiale V; Charpentier J; Cariou A; Chiche JD; Bedos JP; Mira JP
    Crit Care; 2012 Aug; 16(4):R155. PubMed ID: 22894879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related differences in management and outcomes in hospitalized healthy and well-functioning bacteremic pneumococcal pneumonia patients: a cohort study.
    Ruiz LA; España PP; Gómez A; Bilbao A; Jaca C; Arámburu A; Capelastegui A; Restrepo MI; Zalacain R
    BMC Geriatr; 2017 Jun; 17(1):130. PubMed ID: 28633626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Severity scores for predicting clinically relevant outcomes for immunocompetent adult patients hospitalized with community-acquired pneumococcal pneumonia].
    Saldías F; Díaz O
    Rev Chilena Infectol; 2011 Aug; 28(4):303-9. PubMed ID: 22052393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes associated with bacteremia in the setting of methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study.
    Shorr AF; Zilberberg MD; Micek ST; Kollef MH
    Crit Care; 2015 Sep; 19(1):312. PubMed ID: 26335247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia.
    Mykietiuk A; Carratalà J; Domínguez A; Manzur A; Fernández-Sabé N; Dorca J; Tubau F; Manresa F; Gudiol F
    Eur J Clin Microbiol Infect Dis; 2006 Jul; 25(7):457-62. PubMed ID: 16773389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of bacteremia in a cohort of patients with pneumococcal pneumonia.
    Palma I; Mosquera R; Demier C; Vay CA; Famiglietti A; Luna CM
    J Bras Pneumol; 2012; 38(4):422-30. PubMed ID: 22964925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-Acquired Pneumococcal Pneumonia in Virologically Suppressed HIV-Infected Adult Patients: A Matched Case-Control Study.
    Cillóniz C; Torres A; Manzardo C; Gabarrús A; Ambrosioni J; Salazar A; García F; Ceccato A; Mensa J; de la Bella Casa JP; Moreno A; Miró JM
    Chest; 2017 Aug; 152(2):295-303. PubMed ID: 28302496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red cell distribution width as a prognostic marker in patients with community-acquired pneumonia.
    Lee JH; Chung HJ; Kim K; Jo YH; Rhee JE; Kim YJ; Kang KW
    Am J Emerg Med; 2013 Jan; 31(1):72-9. PubMed ID: 22867824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Roles of the Charlson Comorbidity Index and Time to First Antibiotic Dose as Predictors of Outcome in Pneumococcal Community-Acquired Pneumonia.
    Franzen D; Lim M; Bratton DJ; Kuster SP; Kohler M
    Lung; 2016 Oct; 194(5):769-75. PubMed ID: 27405854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-bacteremic pneumococcal pneumonia: general characteristics and early predictive factors for poor outcome.
    Serrano L; Ruiz LA; Martinez-Indart L; España PP; Gómez A; Uranga A; García M; Santos B; Artaraz A; Zalacain R
    Infect Dis (Lond); 2020 Sep; 52(9):603-611. PubMed ID: 32552142
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.
    Jover F; Cuadrado JM; Andreu L; Martínez S; Cañizares R; de la Tabla VO; Martin C; Roig P; Merino J
    Eur J Intern Med; 2008 Jan; 19(1):15-21. PubMed ID: 18206596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal pneumonia - Are the new severity scores more accurate in predicting adverse outcomes?
    Ribeiro C; Ladeira I; Gaio AR; Brito MC
    Rev Port Pneumol; 2013; 19(6):252-9. PubMed ID: 23850193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.